We have a number of resources and guidelines that can help with experimental design.

Dementia Researcher: a network for early career researchers

Delivered by NIHR and supported by Alzheimer's Research UK and Alzheimer's Society,  Dementia Researcher is a website that allows you to pick up advice and chat with peers while bringing together all the latest jobs, events and funding opportunities. Become a member and get access to a range of great benefits including:

  • Find - all the latest jobs and funding opportunities in dementia research
  • Search – for workshops, training and events for you
  • Tools & Support – everything from producing a grant proposal to ways of engaging patients and the public in your research
  • Careers – advice and tips from established researchers and interactive tools to help steer you in the right direction
  • Community – stay in touch with other early career researchers on our forums and messenger service

Observe our Grant Review Board

The Alzheimer's Research UK Grant Review Board meets twice a year to discuss applications and make recommendations for which projects should be funded. We offer early career researchers (Postdocs and Fellows) the chance to observe these meetings to gain insight into the review process. The next Grant Review Board is in January and applications to observe will open in October.

International Alzheimer’s Disease Research Portfolio

You can use the International Alzheimer's Disease Research Portfolio (IADRP) online database to visualize and track changes in the Alzheimer’s disease research landscape, identify gaps in critical research areas, explore opportunities for collaboration and avoid duplication in funding. The database is supported by the US National Institute of Aging and the Alzheimer’s Association with the participation of several international funders including Alzheimer’s Research UK.

Research projects

We believe in the power of research to change the future.

A research scientist next to a large microscope

Grant writing for Success

We hosted a ‘Grant Writing for Success’ seminar with the British Neuroscience Association, to share insights into funding opportunities from Alzheimer’s Research UK and top tips from Prof David Dexter, who sits on a number of grant review boards.

Play Video

Funding opportunities from Alzheimer’s Research UK

Dr Rosa Sancho, Head of Research at Alzheimer’s Research UK

Play Video

How to write a good grant

Prof David Dexter, Professor of Neuropharmacology, Imperial College London

Publishing your work

Alzheimer’s Research UK believes that making the outputs of research freely available as widely as possible is essential to the advancement of dementia science. We promote open access publishing and data sharing to foster collaboration among researchers, allow for information to be shared with supporters and people with dementia, and create a richer research environment.

Alzheimer’s Research UK is a founding partner of AMRC Open Research. AMRC Open Research is an open access publishing platform set up by 24 Association for Medical Research member charities, in partnership with F1000. This platform operates an alternative publication model that enables research funded by the participating charities to be and immediately published, followed by open peer review. We encourage researchers to consider AMRC Open Research as an option for disseminating the results of their research.

Alzheimer’s Research UK is also affiliated with the journal Alzheimer’s Research and Therapy. An international peer-reviewed journal, Alzheimer's Research & Therapy publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies.

Brains for Dementia Research

Brains for Dementia Research (BDR) is a joint initiative between Alzheimer’s Research UK and Alzheimer’s Society, in association with the Medical Research Council, which aims to provide high quality human brain tissue to the dementia research community. Not only does BDR provide ‘gold standard’ histopathological samples (including age-matched controls), but each prospective donor takes part in regular, standardised cognitive assessments. As such, donated brain tissue comes which a rich medical history - a unique feature of BDR over other sources of brain tissue.

The scheme is open to researchers in the UK and internationally. BDR can grant ‘generic ethical approval’ to UK based researchers. This will, in most cases, enable studies to proceed without researchers being required to obtain their own ethical approval, although there may be local institution regulations in place.

Alzheimer’s Research UK encourages researchers to consider the use of BDR tissue, where appropriate, in their grant applications.

The National Institute of Health Research and the Clinical Research Network

Alzheimer’s Research UK is a National Institute for Health Research (NIHR) non-commercial Partner. This means the studies that we fund may be eligible to access NIHR Clinical Research Network (CRN) support.

In partnership with your local R&D office, we encourage you to involve your local CRN team in discussions as early as possible when planning your study to fully benefit from the support the NIHR CRN offers as outlined in their Study Support Service.

If your study involves NHS sites in England you will need to apply for Health Research Authority Approval.

Dementias Writing Group support for clinical grant applications

Portfolio Development Groups (PDGs) aim to provide advice and support for researcher groups working together to submit grant applications to fund clinical studies.

The Dementias PDG is composed of experts and lay members within the Dementia field that promote the development of innovative ideas into funded research. This includes supporting Writing Groups to formulate and write grant applications.

Expressions of interest from researchers interested in applying to Writing Groups support are now being accepted. Support offered includes practical advice over expertise, applicants, patient involvement and study design, as well as logistic support for writing group meetings and post-award advice.

If you have an outstanding idea with the potential to advance clinical knowledge of dementia in the UK and are interested in receiving support from the Dementias PDG, please complete the following form.

We aim to assess whether the Dementias PDG can support your proposal within 1 month of submission. Please contact us if you have not heard within this timeframe. If you have any queries, please contact admin.NDDR@nihr.ac.uk.

Join Dementia Research

Are you looking for ways to boost your study recruitment?

Do you want to see if a future study would be possible?

‘Join dementia research’ is a fantastic service developed by the NIHR in partnership with Alzheimer’s Research UK and Alzheimer’s Society, which allows the public to register their interest in getting involved in research studies. The aim of Join Dementia Research is to improve the timeliness of study recruitment for researchers, and provide a service to thousands of potential volunteers who want to be involved in research.

For those planning research studies in care homes, please take a look at the NIHR toolkit for Enabling Research in Care Homes.

Dementias Platform UK

Dementias Platform UK (DPUK) is a multi-million pound public-private partnership, developed and led by the Medical Research Council. DPUK is creating an optimal environment for dementias research by aligning information from over 25 longitudinal cohort studies and enriching certain datasets. Researchers will have easier access to data to support their research, which will be retrieved via a single point. For more information please contact info@dementiasplatform.uk

National Centre for the Replacement Refinement and Reduction of Animals in Research – the ARRIVE guidelines

The ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines have been developed by the NC3Rs and are intended to improve standards of reporting and ensure that the data from animal experiments can be fully evaluated and utilised. When planning animal studies, please take a look at guidelines from the NC3Rs for experimental design. Researchers using animals are expected to give appropriate consideration to the 3Rs (Replacement, Refinement and Reduction), make use of the ARRIVE guidelines when designing their experiments, and ensure that they report animal-based studies in accordance with the ARRIVE guidelines as far as possible, taking into account the specific editorial policies of the journal concerned.

To get more tips about implementing the 3Rs into your grant applications by watching the video below.

Play Video

Join our Network

The Alzheimer’s Research UK Research Network is a community of over 1,800 researchers across the UK, with each Network Centre providing pump priming, travel and equipment funding as well as local networking events.

Our research strategy

Our focus is to accelerate the ‘bench-to-bedside’ journey: our funding seeks to translate scientific findings into patient benefit as rapidly as possible.

Looking for funding?

We have a wide range of flexible and responsive grant schemes for both clinical and basic researchers, including project, career development and equipment grants.

Upcoming paper?

Let us know! We like to shout about the great work our researchers are doing. Tell us when you submit a paper and we can help to get your research more coverage.

Leave a Comment